[Risk factors related to cardiovascular complications in patients diagnosed with Kawasaki disease in northwestern

Olivia A Flores-Montes1, Jaime Valle-Leal1, Roberto Arreguin-Reyes2

  • 1Departamento de Pediatría. Hospital General Regional 1, Instituto Mexicano del Seguro Social, Ciudad Obregón, Sonora, México.

Insights

Kawasaki disease (KD) is a serious condition in children. Male gender, young age, and anemia are key risk factors for developing cardiovascular complications in pediatric KD patients.

Area of Science:

  • Pediatric Rheumatology
  • Cardiovascular Health
  • Systemic Vasculitis

Background:

  • Kawasaki disease (KD) is an acute febrile illness affecting small to medium blood vessels in children.
  • Untreated KD patients have a 25% risk of developing coronary artery abnormalities.
  • Early identification of risk factors is crucial for managing KD's cardiovascular sequelae.

Purpose of the Study:

  • To describe the clinical presentation of Kawasaki disease in pediatric patients.
  • To identify risk factors associated with cardiovascular complications in children diagnosed with KD.
  • To inform clinical management strategies in a secondary-level hospital setting.

Main Methods:

  • A case series design was employed to study pediatric patients diagnosed with KD.
  • Clinical and laboratory variables were assessed, along with the incidence of cardiac complications.
  • Odds ratios (OR) and chi-squared tests were used to determine risk and association.

Main Results:

  • The study included 12 pediatric patients, with a predominance of females; the mean age was 2 years.
  • All patients presented with complete KD symptoms, alongside atypical manifestations.
  • Cardiovascular complications were observed in 50% of patients, with coronary disease being the most frequent (33%).
  • Male gender, age under 2 years, and anemia were associated with increased odds of cardiovascular complications (OR 5.5 and 10).

Conclusions:

  • Cardiovascular complications are a frequent outcome in pediatric patients with Kawasaki disease, occurring in over 30% of cases.
  • Specific risk factors, including male gender, younger age (under 2 years), and anemia, significantly elevate the likelihood of developing cardiovascular complications.
  • These findings underscore the importance of vigilant monitoring and risk factor assessment in pediatric KD management.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.7K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
580
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
332
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.3K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.4K